Moreover, BATF3 can influence the apoptosis and longevity of T cells via the proapoptotic factor BIM, indicating that BATF3 has the potential to optimize adoptive T-cell therapy (ACT) in cancer patients (58). Here, BCL2L11 is linked to cancer.